Which patient should be advised by the nurse to avoid over-the-counter cold and allergy preparations that contain phenylephrine?
A 47-year-old female with hypertension
A 52-year-old male with adult-onset diabetes
A 17-year-old female with symptoms of an upper respiratory infection
A 62-year-old male with gout
The Correct Answer is A
A. Phenylephrine is a decongestant that can raise blood pressure, making it contraindicated for individuals with hypertension. Advising a patient with hypertension to avoid phenylephrine is essential to prevent potential cardiovascular complications.
B. While patients with diabetes should be cautious about certain medications, phenylephrine is not specifically contraindicated in this condition.
C. A 17-year-old female with an upper respiratory infection typically does not have contraindications for phenylephrine unless there are underlying conditions not mentioned.
D. Gout does not have a direct contraindication for phenylephrine use, so the patient may not need to avoid it unless other health issues are present.
Free Nursing Test Bank
- Free Pharmacology Quiz 1
- Free Medical-Surgical Quiz 2
- Free Fundamentals Quiz 3
- Free Maternal-Newborn Quiz 4
- Free Anatomy and Physiology Quiz 5
- Free Obstetrics and Pediatrics Quiz 6
- Free Fluid and Electrolytes Quiz 7
- Free Community Health Quiz 8
- Free Promoting Health across the Lifespan Quiz 9
- Free Multidimensional Care Quiz 10
View Related questions
Correct Answer is C
Explanation
A. It has a peak effect of 4-6 hours is incorrect; short-acting insulin typically peaks between 2 to 3 hours after administration.
B. It should be given once daily in the evening is incorrect; short-acting insulin is usually administered before meals, not as a once-daily dose.
C. It starts to take effect within 30 minutes to 1 hour after administration is correct; this timing is critical for managing blood glucose levels during meals.
D. It has a duration of action of 24 hours is incorrect; short-acting insulin usually has a duration of about 3 to 6 hours.
Correct Answer is A
Explanation
A. Spironolactone is a potassium-sparing diuretic, meaning it helps retain potassium while promoting sodium and water excretion. This makes it advantageous for clients who may be at risk for hypokalemia with furosemide, which can lead to significant potassium loss.
B. This statement is incorrect; spironolactone causes less potassium loss compared to furosemide, making it a better option for those needing to maintain potassium levels.
C. This statement is misleading; spironolactone does promote diuresis but does not cause greater water losses than furosemide.
D. This is incorrect; while spironolactone does promote sodium excretion, it does not do so to a greater extent than furosemide, which is a more potent diuretic.